Trial Profile
A Phase II/III trial of SB-04 for dry Age-related Macular Degeneration
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 21 May 2018
Price :
$35
*
At a glance
- Drugs MC 1101 (Primary)
- Indications Dry age-related macular degeneration
- Focus Adverse reactions; Therapeutic Use
- 21 May 2018 New trial record
- 14 May 2018 According to a SynCore Bio media release, on an ongoing basis, the patients involved in the study have achieved 1/4 of the goal. This trial is being carried out by National Taiwan University Hospital, Changhua Christian Hospital, and Kaohsiung Veterans General Hospital.